Allergy Relief (loratadine) NDC 51660-527

NDC codes

FDA NDC Directory

Product NDC (as listed)51660-527Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51660-0527Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51660-527-31	51660052731	30 BLISTER PACK in 1 CARTON (51660-527-31) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Aug 31, 2007

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Allergy Relief
Generic name (nonproprietary): loratadine
Active ingredients: Loratadine — 10 mg/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: Ohm Laboratories Inc.
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077153
Marketing start: Aug 31, 2007
Listing expires: Dec 31, 2026
Identifiers: Product ID 51660-527_7b87d8ea-1102-4642-8a39-b2504dbda716SPL ID 7b87d8ea-1102-4642-8a39-b2504dbda716SPL set ID de3a7725-5d1b-4195-a9f8-43f92888997cRxCUI 311373UNII 7AJO3BO7QN

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451660052731 followed by a unit qualifier and the quantity

Package 51660-0527-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 6, 2021.

Indications (excerpt from the label)

USES Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • itchy, watery eyes • sneezing • itching of the nose or throat

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)